Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spero Therapeutics, Inc. has filed 508 SEC EDGAR filings since 21 Mar 2017

SEC filing history

Showing 426-450 of 508 matching filings.

Per page
25
Current page
18
8-K File 001-38266

8-K

Filing date
16 Jul 2018
Reporting date
16 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-226093

424B4

Filing date
13 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-226093

EFFECT filing

Filing date
12 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-226093

S-1/A

Filing date
11 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
09 Jul 2018
Reporting date
09 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
09 Jul 2018
Reporting date
09 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2018
Reporting date
05 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2018
Reporting date
05 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2018
Reporting date
05 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

FORM 8-K

Filing date
08 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-02085

DRS filing

Filing date
25 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
10 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38266

SPERO THERAPEUTICS, INC. Q1 2018 10-Q

Filing date
10 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
DEF 14A File 001-38266

DEF14A

Filing date
27 Apr 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
02 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Mar 2018
Reporting date
30 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90168

SC 13D

Filing date
14 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .